Linda E. Greenbaum

Novartis (United States) — United States

Medicine · Health Sciences

31h-index5.7kcitations61works9.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver physiology and pathology(27), Liver Disease Diagnosis and Treatment(16), Pancreatic function and diabetes(12), Organ Transplantation Techniques and Outcomes(6), Inflammatory Bowel Disease(5)

Publications59 total

Editorial: Combination Therapies for <scp>MASH</scp> : A Step Forward or More Complexity? Authors' Reply
Alimentary Pharmacology & Therapeutics·2025
Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction–Associated Steatohepatitis
Alimentary Pharmacology & Therapeutics·2025· 2 citedOpen Access
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo
Cell stem cell·2024· 27 cited
Clinical translation of liver regeneration therapies: A conceptual road map
Biochemical Pharmacology·2020· 15 cited
YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury
Cell stem cell·2019· 206 citedOpen Access
OP36 A colonic gene expression signature predicts non-response to anti-inflammatory therapies in inflammatory bowel disease
Journal of Crohn s and Colitis·2019Open Access
A Simplified Definition of Histologic Improvement in Ulcerative Colitis and its Association With Disease Outcomes up to 30 Weeks from Initiation of Therapy: Post Hoc Analysis of Three Clinical Trials
Journal of Crohn s and Colitis·2019· 18 cited
Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis
Gastroenterology·2018· 68 citedOpen Access
Prediction of Non-Response to Anti-Tnf Therapy in Ulcerative Colitis: Implications for Patient Stratification for IBD Trials and Novel Treatment Paradigms
Gastroenterology·2017· 1 cited
Histological Remission in UC: An Analysis of two Independent Cohorts
Gastroenterology·2017· 1 cited
P077 Histological remission in ulcerative colitis: an analysis of two independent cohorts
Journal of Crohn s and Colitis·2017Open Access
Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy
PLoS ONE·2016· 11 citedOpen Access
Genetic lineage tracing analysis of the cell of origin of hepatotoxin‐induced liver tumors in mice
Hepatology·2016· 81 citedOpen Access
A genetic screen reveals Foxa3 and TNFR1 as key regulators of liver repopulation
Genes & Development·2015· 49 citedOpen Access
Protein tyrosine phosphatase of liver regeneration-1 is required for normal timing of cell cycle progression during liver regeneration
American Journal of Physiology-Gastrointestinal and Liver Physiology·2014· 19 citedOpen Access
Ablation of Foxl1-Cre–Labeled Hepatic Progenitor Cells and Their Descendants Impairs Recovery of Mice From Liver Injury
Gastroenterology·2014· 80 citedOpen Access
Idiopathic Myointimal Hyperplasia of the Mesenteric Veins
The American Surgeon·2014· 11 cited
644 A Genetic Screen to Identify and Rank Regulators of Liver Repopulation Following Toxic Injury
Gastroenterology·2014
The Impact of Diet Liberalization on Bowel Preparation for Colonoscopy
The American Journal of Gastroenterology·2013· 7 cited
Dynamic recruitment of microRNAs to their mRNA targets in the regenerating liver
BMC Genomics·2013· 67 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Rebecca Taub(14), Klaus H. Kaestner(14), Rebecca G. Wells(5), Barbara Haber(5), Drew E. Cressman(4), Soona Shin(4), Jonathan Schug(4), Yan Gao(4), Carrie Brodmerkel(4), Katherine Li(4), Gennaro Ciliberto(3), Kellen Kovalovich(3), Jan S. Tchorz(3), Karrie Brondell(3), Yong Peng(3), Richard Strauß(3), Joshua R. Friedman(3), John Le Lay(3), T. Harshani Peiris(3), Robert A. DeAngelis(2)